SG11083G - Glucosamine derivatives and a process for their manufacture - Google Patents

Glucosamine derivatives and a process for their manufacture

Info

Publication number
SG11083G
SG11083G SG110/83A SG11083A SG11083G SG 11083 G SG11083 G SG 11083G SG 110/83 A SG110/83 A SG 110/83A SG 11083 A SG11083 A SG 11083A SG 11083 G SG11083 G SG 11083G
Authority
SG
Singapore
Prior art keywords
manufacture
glucosamine derivatives
glucosamine
derivatives
Prior art date
Application number
SG110/83A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SG11083G publication Critical patent/SG11083G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG110/83A 1975-12-10 1983-03-14 Glucosamine derivatives and a process for their manufacture SG11083G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1604275A CH613709A5 (en) 1975-12-10 1975-12-10 Process for the preparation of glucosamine derivatives

Publications (1)

Publication Number Publication Date
SG11083G true SG11083G (en) 1983-09-16

Family

ID=4414012

Family Applications (1)

Application Number Title Priority Date Filing Date
SG110/83A SG11083G (en) 1975-12-10 1983-03-14 Glucosamine derivatives and a process for their manufacture

Country Status (30)

Country Link
JP (1) JPS5273820A (no)
AR (2) AR224091A1 (no)
AT (1) AT365607B (no)
AU (1) AU508764B2 (no)
BE (1) BE849214A (no)
CA (1) CA1262400A (no)
CH (2) CH613709A5 (no)
CS (4) CS205026B2 (no)
DD (1) DD129781A5 (no)
DE (1) DE2655500A1 (no)
DK (1) DK154654C (no)
ES (2) ES454118A1 (no)
FI (1) FI64164C (no)
FR (1) FR2361902A1 (no)
GB (1) GB1570625A (no)
GR (1) GR61647B (no)
HK (1) HK32883A (no)
HU (1) HU177970B (no)
IE (1) IE44190B1 (no)
IL (1) IL51076A (no)
MY (1) MY8400123A (no)
NL (1) NL7613666A (no)
NO (1) NO144850C (no)
NZ (1) NZ182837A (no)
PL (4) PL110787B1 (no)
PT (1) PT65946B (no)
SE (1) SE445923B (no)
SG (1) SG11083G (no)
SU (3) SU660589A3 (no)
ZA (1) ZA767333B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4370265A (en) * 1974-10-22 1983-01-25 Agence Nationale De Valorisation Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
GB1571133A (en) * 1976-04-26 1980-07-09 Syntex Inc Immuniological adjuvant peptidoglycans compounds and methods of preparation thereof
DE2862107D1 (en) 1977-12-02 1982-11-18 Takeda Chemical Industries Ltd Glucosamine-peptide derivatives and their pharmaceutical compositions
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
CA1138436A (en) * 1978-02-24 1982-12-28 Gerhard Baschang Process for the manufacture of novel antigens
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
FR2420545A1 (fr) * 1978-03-20 1979-10-19 Anvar Nouveaux esters de l'acide n-acetyl-muramyl-aminoacyl-glutamique ou des derives de substitution de celui-ci a proprietes anti-infectieuses et/ou d'adjuvants immunologiques
FR2428050A1 (fr) * 1978-06-05 1980-01-04 Anvar Oligomeres de composes du type muramyl-peptide et medicaments les contenant
FR2428051A1 (fr) * 1978-06-05 1980-01-04 Anvar Nouveaux composes du type muramyl-peptide et medicaments les contenant
FR2446292A1 (fr) * 1979-01-12 1980-08-08 Anvar Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant
US4256735A (en) 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
FR2449697A1 (fr) 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
FI75578C (fi) 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
JPS5649396A (en) * 1979-09-28 1981-05-02 Dai Ichi Seiyaku Co Ltd Novel muramyldipeptide derivative
EP0026746B1 (de) * 1979-10-02 1985-04-10 Ciba-Geigy Ag Kombinationspräparate zur Anwendung in einem Verfahren zur Steigerung der Wirkung von Antibiotika, antibiotische Präparate mit gesteigerter Wirksamkeit und Verfahren zu deren Herstellung
FI803077A (fi) 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider
US4409209A (en) * 1979-10-12 1983-10-11 Ciba-Geigy Corporation Novel phosphorylmuramyl peptides and processes for the manufacture thereof
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
US4310514A (en) 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
EP0056560A1 (de) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika
GR78246B (no) * 1981-01-23 1984-09-26 Ciba Geigy Ag
JPS6042398A (ja) * 1983-08-18 1985-03-06 Toshiyuki Hamaoka ムラミルジペプチド活性エステル誘導体
EP0541486A1 (de) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
WO2006118327A1 (ja) * 2005-04-27 2006-11-09 Oxygenix Co Ltd カチオン性アミノ酸型脂質
WO2016138286A1 (en) 2015-02-26 2016-09-01 Stc.Unm Irgm and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
US10927147B2 (en) 2015-12-10 2021-02-23 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
US10576147B2 (en) * 2015-12-15 2020-03-03 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
MX2020002010A (es) 2017-08-21 2020-07-13 Celgene Corp Procesos para la preparacion de 4,5-diamino-5-oxopentanoato de (s)-terc-butilo.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

Also Published As

Publication number Publication date
AR220686A1 (es) 1980-11-28
FI64164B (fi) 1983-06-30
ZA767333B (en) 1977-11-30
DK154654C (da) 1989-05-08
CH613709A5 (en) 1979-10-15
SU747430A3 (ru) 1980-07-23
FR2361902B1 (no) 1980-11-07
DK552476A (da) 1977-06-11
IE44190B1 (en) 1981-09-09
CS205028B2 (en) 1981-04-30
SE7613851L (sv) 1977-06-11
DD129781A5 (de) 1978-02-08
PL110353B1 (en) 1980-07-31
PT65946B (en) 1978-06-14
FR2361902A1 (fr) 1978-03-17
PL194291A1 (pl) 1978-10-23
MY8400123A (en) 1984-12-31
AT365607B (de) 1982-02-10
NL7613666A (nl) 1977-06-14
DE2655500C2 (no) 1988-12-22
FI763541A (no) 1977-06-11
ATA909276A (de) 1981-06-15
PL110787B1 (en) 1980-07-31
ES454118A1 (es) 1978-03-01
NO144850C (no) 1981-11-25
PL110794B1 (en) 1980-07-31
HK32883A (en) 1983-09-02
NZ182837A (en) 1978-07-28
CS205025B2 (en) 1981-04-30
CS205027B2 (en) 1981-04-30
CS205026B2 (en) 1981-04-30
DE2655500A1 (de) 1977-06-23
AR224091A1 (es) 1981-10-30
DK154654B (da) 1988-12-05
IL51076A (en) 1980-09-16
FI64164C (fi) 1983-10-10
IE44190L (en) 1977-06-10
CA1262400A (en) 1989-10-17
BE849214A (fr) 1977-06-09
JPS638118B2 (no) 1988-02-19
PL112672B1 (en) 1980-10-31
IL51076A0 (en) 1977-02-28
GB1570625A (en) 1980-07-02
GR61647B (en) 1978-12-05
AU508764B2 (en) 1980-04-03
JPS5273820A (en) 1977-06-21
SU660589A3 (ru) 1979-04-30
HU177970B (en) 1982-02-28
ES465514A1 (es) 1978-09-16
SE445923B (sv) 1986-07-28
AU2042276A (en) 1978-06-15
PT65946A (en) 1977-01-01
SU1060118A3 (ru) 1983-12-07
CH614718A5 (en) 1979-12-14
NO144850B (no) 1981-08-17
NO764191L (no) 1977-06-13

Similar Documents

Publication Publication Date Title
SG11083G (en) Glucosamine derivatives and a process for their manufacture
ZA775652B (en) Fortimicin b derivatives and process for production thereof
HU172929B (hu) Sposob poluchenija proizvodnykh pirido-pirimido- ili tiazolo-kinazolinov
GB1549047A (en) Prost-16-ynoic acid and derivatives and process for their manufacture
GB1550230A (en) Phenylindolines and process for their production
JPS5259134A (en) New aminoglycoside derivatives and process for manufacture thereof
IL49681A0 (en) New eburnamenine derivatives and a process for the preparation thereof
JPS524536A (en) 22hydroxybenzantron and process for producing substituted derivatives thereof
GB1549342A (en) 11-oxo-prostaglandin derivatives and processes for their manufacture
HU175266B (hu) Sposob poluchenija materialy dezacetil 890 a1 i dezacetil 890 a3
JPS51146438A (en) New cyclopropanol derivatives and process for manufacture thereof
IL50436A (en) 4-halomethyl-or hydroxymethyl-2-pyrrolidinone and 4-aminomethyl-tetrahydrofuran-2-one derivatives and their production
ZA762785B (en) New benzo-diazepin derivatives and a process for their manufacture
ZA765320B (en) Antibiotic a-30912 and process for production thereof
GB1537901A (en) Aminocyclitol derivatives and a process for producing the same
ZA764162B (en) Fortimicin c and process for production thereof
GB1482879A (en) 5-benzyl-2-oxazolidone derivatives and a process for producing the same
ZA763135B (en) New prostane derivatives and process for their maunfactur
IL49716A0 (en) New thienyl-prostaglandins and process for their manufacture
KE2862A (en) A process for the manufacture of benodiazepine derivatives
HU172549B (hu) Sposob poluchenija proizvodnykh 3-tetrazolil-gamma-kromona
GB1554950A (en) D - homo - 20 - keto -steroids and process for their manufacture
GR63597B (en) Fortimicin b derivatives and process for production thereof
JPS5223074A (en) Hexahydroo2hhindazole derivatives and production thereof
HU173109B (hu) Sposob poluchenija proizvodnykh imidazolobenzodiazepinov